2019
DOI: 10.1080/13506129.2019.1582520
|View full text |Cite
|
Sign up to set email alerts
|

Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?